John Temperato
Net Worth

Last updated:

What is John Temperato net worth?

The estimated net worth of Mr. John Temperato is at least $3,394,960 as of 6 Jul 2022. He owns shares worth $132,760 as insider and has received compensation worth at least $3,262,200 in 9 Meters Biopharma, Inc..

What is the salary of John Temperato?

Mr. John Temperato salary is $652,440 per year as Pres, Chief Executive Officer & Director in 9 Meters Biopharma, Inc..

How old is John Temperato?

Mr. John Temperato is 60 years old, born in 1965.

What stocks does John Temperato currently own?

As insider, Mr. John Temperato owns shares in one company:

Company Title Shares Price per share Total value
9 Meters Biopharma, Inc. (NMTR) Pres, Chief Executive Officer & Director 1,427,522 $0.09 $132,760

What does 9 Meters Biopharma, Inc. do?

9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as well as in Phase IIa clinical trial for treatment of multi-system inflammatory syndrome; and Vurolenatide, a long-acting injectable glucagon-like-peptide-1 that is in Phase 2 clinical trial to treat short bowel syndrome. It also develops NM-102, a small molecule peptide; NM-003, a proprietary long-acting glucagon-like peptide-2 receptor agonist for prevention of acute graft versus host disease; NM-136, a humanized monoclonal antibody for targeted obesity disorders; and NM-004, a double-cleaved mesalamine with an immunomodulator for rare and/or orphan indications. The company is based in Raleigh, North Carolina.

NMTR logo
NMTR
9 Meters Biopharma, Inc.
$0.09

John Temperato insider trading

9 Meters Biopharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common stock 125,000 $0.23 $28,500
Purchase
Common Stock 50,000 $0.45 $22,300
Purchase
Common stock 100,000 $0.56 $55,600
Purchase
Common stock 50,000 $1.05 $52,500
Purchase
Common stock 25,000 $1.05 $26,250
Purchase
Common stock 100,000 $1 $100,000
Purchase
Common stock 153,846 N/A N/A
Purchase
Common stock 70,000 N/A N/A
Purchase
Common stock 35,000 N/A N/A
Purchase
Common stock 10,000 $0.6 $5,970
Purchase
Series A Convertible Preferred Stock 2,714 N/A N/A

9 Meters Biopharma key executives

9 Meters Biopharma, Inc. executives and other stock owners filed with the SEC:

  • Dr. Patrick H. Griffin (70) Chief Medical Officer
  • Mr. Edward J. Sitar CPA, CPA (62) Chief Financial Officer
  • Mr. John Temperato (60) Pres, Chief Executive Officer & Director